The overexpression of IF1 in NSCLC as assessed by non-quantitative immunohistochemistry has been suggested to predict bad patients’ prognosis [30] in contrast with our findings (Fig. 2b; Table 1). This evidence concerns the gene ATP5IF1 and non-small cell lung carcinoma.